Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

AIM: To investigate the feasibility of preoperative docetaxel, cisplatin and capecitabine (DCC) in patients with resectable gastric cancer. METHODS: Patients with resectable gastric cancer fulfilling the inclusion criteria, were treated with 4 cycles of docetaxel (60 mg/m(2)), cisplatin (60 mg/m(2))...

Descripción completa

Detalles Bibliográficos
Autores principales: Dassen, Anneriet E, Bernards, Nienke, Lemmens, Valery E P P, van de Wouw, Yes A J, Bosscha, Koop, Creemers, Geert-Jan, Pruijt, Hans J F M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081553/
https://www.ncbi.nlm.nih.gov/pubmed/27830043
http://dx.doi.org/10.4240/wjgs.v8.i10.706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081553/
https://www.ncbi.nlm.nih.gov/pubmed/27830043
http://dx.doi.org/10.4240/wjgs.v8.i10.706

Ejemplares similares